-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on CVS Health, Raises Price Target to $80

Benzinga·08/01/2025 13:06:06
Listen to the news
Barclays analyst Andrew Mok maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $79 to $80.